Related Experiment Video
Updated: Aug 11, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and
M Nakamura1, T Matsuo, J Stauffer
1Cell and Molecular Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Abstract:
Poor prognosis neuroblastoma (NB) tumors are marked by amplification and overexpression of N-myc. Retinoic acid (RA) decreases N-myc levels and induces cell cycle arrest in vitro and increases event-free survival in advanced stage NB patients. In this study, we investigated the mechanism(s) by which RA regulates cell cycle and how N-myc affects NB cell cycle progression. Constitutive N-myc overexpression stimulates increases in cyclin E-dependent kinase activity and decreases in p27 resulting in increased DNA synthesis. N-myc regulates p27 levels through an increase in targeting of p27 to the proteasome via cyclin E kinase-dependent phosphorylation of p27 and its ubiquitination. N-myc also stimulates an increase in proteasome activity. In RA-treated cells in which N-myc levels decline as p27 levels increase, degradation of p27 is also decreased. However, RA does not affect the activity of proteasome. The decrease in the degradation of p27 in RA-treated cells is due in part to a decrease in the N-myc stimulated phosphorylation of p27. However, RA also decreases Skp2 levels thus impairing the ability of p27 to be ubiquitinated. Thus, RA induces both N-myc-dependent and -independent mechanisms to minimize the degradation of p27 and arrest NB cell growth.
Insights
Retinoic acid (RA) combats neuroblastoma (NB) by reducing N-myc and increasing p27 levels, halting cancer cell growth. RA achieves this through N-myc-dependent and -independent pathways, inhibiting p27 degradation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Neuroblastoma (NB) prognosis is linked to N-myc amplification and overexpression.
- Retinoic acid (RA) shows therapeutic potential by decreasing N-myc and inducing cell cycle arrest in NB.
Purpose of the Study:
- To elucidate the mechanisms of RA-induced cell cycle regulation in NB.
- To understand how N-myc influences NB cell cycle progression.
Main Methods:
- Investigated the role of N-myc in regulating cyclin E-dependent kinase activity and p27 levels.
- Assessed the impact of N-myc on p27 targeting to the proteasome and proteasome activity.
- Examined RA's effects on N-myc levels, p27 degradation, phosphorylation, ubiquitination, and Skp2 levels.
Main Results:
- N-myc overexpression increases cyclin E-dependent kinase activity, decreases p27, and enhances DNA synthesis.
- N-myc promotes p27 degradation via phosphorylation and ubiquitination, increasing proteasome activity.
- RA treatment reduces N-myc, increases p27, and decreases p27 degradation through both N-myc-dependent and -independent pathways, including reduced p27 phosphorylation and lower Skp2 levels.
Conclusions:
- RA effectively arrests NB cell growth by stabilizing p27.
- Both N-myc-dependent and -independent mechanisms contribute to RA's anti-neuroblastoma effects.
- Targeting p27 stabilization presents a promising therapeutic strategy for neuroblastoma.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Anaphase Promoting Complex
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

